The reported cuts to US science aid aren't just budget trimming; they are a geopolitical strategy eroding global scientific literacy and trust.
Forget the breakthroughs. The real story in February's science snapshots isn't discovery, it's geopolitical control over future technology.
The official visit of Japan's top science advisor signals a desperate pivot in global **technology transfer**—and the US might be the unwitting supplier.
The impending loss of a UK generation of scientists due to research cuts isn't just a domestic failure; it's a geopolitical gift to global competitors.
The battle over federal science funding isn't about budgets; it's about control. Discover who truly benefits from crippling U.S. research.
The UNESCO and UWI WISE initiative champions women in science, but the real story is about controlling the future narrative of Caribbean scientific innovation.
Russian scientists unveil a breakthrough cancer treatment technology. But the real story isn't the science; it's the geopolitical chessboard.
Forget 'cooperation.' The push for collaborative science in marine conservation hides a brutal power play over future fishing rights and data monopolies.
US science funding faces four critical forks by 2026. The real story isn't innovation; it's geopolitical control and the hidden cost of scientific decoupling.
Forget the job promises. The new UK-US tech and drug discovery partnership hides a deeper, strategic battle over intellectual property and AI dominance in life sciences.
The new Luxembourg science centre promises public engagement, but it's really a sophisticated talent pipeline for the EU's deep-tech future.
The 2025 science headlines masked the real power shift. Unpacking the untold economic and geopolitical cost of the year's biggest scientific leaps.